European Oncology Head and Neck Cancer Awareness Week in Russia

Partnership Objective 

In Septemebr 2014, Merck participated in the European Oncology Head and Neck Cancer Awareness Week in Russia as part of efforts to raise awareness of head and neck cancer symptoms among general population and healthcare workers.

During the one week campaign, over 6,200 patients in 17 cities gained access to quality testing, screening and care in line with international standards. During the one week campaign, over 6,200 patients in 17 cities gained access to quality testing, screening and care in line with international standards. Copyright Merck, Getty Images

What are the health needs and challenges?

Cancers of the head and neck are the fifth most common cancer worldwide and account for more than 550,000 cases diagnosed each year. According to MNIOI report 2012, some 50,000 patients in Russia have cancer of the head and neck.

Description of partnership activities and how they address needs and challenges

In Russia, Merck participated in the European Oncology Head and Neck Cancer Awareness Week in Russia as part of efforts to raise awareness of head and neck cancer symptoms among general population and healthcare workers.  This initiative was supported locally by the Federation of Head and Neck specialists, Russian Society of Head and Neck specialists. In order to comprehensively and holistically raise awareness about head and neck cancer, multidisciplinary teams of oncologists, ear, nose and throat doctors as well as dentists were involved. As part of an extensive information campaign, various sources information channels were used including regional TV, internet, social network, radio, printed materials and federal call-center. The campaign covered 32 clinics in 17 cities and 6,242 patients were examined with 609 cancer and pre-cancer patients diagnosed.

During the one week campaign, over 6,200 patients in 17 cities gained access to quality testing, screening and care in line with international standards.

Videos

Partnerships for better early diagnosis

Partnership information

Company(ies) Merck

Partner(s) Russian Federation of Head and Neck Specialists

Type of Partner(s) Professional Associations

Therapeutic Focus Non-Communicable Diseases

Disease(s) Cancer

Program Type(s) Availability of Treatment - NCDs Access Programs, Prevention Programs - Awareness & Outreach

Targeted Population(s) General population

Region(s) Europe & Central Asia

Number of Countries 1

Country(ies) Russia

Start Date 2014

More information EMD Magazine

Anticipated completion date Ongoing